{
    "clinical_study": {
        "@rank": "75500", 
        "acronym": "OMEMI", 
        "arm_group": [
            {
                "arm_group_label": "Pikasol", 
                "arm_group_type": "Active Comparator", 
                "description": "Pikasol\u00ae, 3 capsules (1.8 g EPA+DHA)/day"
            }, 
            {
                "arm_group_label": "Corn oil", 
                "arm_group_type": "Placebo Comparator", 
                "description": "3x capsules of corn oil pr day"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the present study is to investigate the possible effects of supplementation with\n      1.8 g/day of n-3 polyunsaturated fatty acids on cardiovascular morbidity and mortality\n      during a follow-up period of 2 years in an elderly population after having experienced an\n      acute myocardial infarction.\n\n      The hypothesis is that this supplementation on top of modern therapy will reduce the\n      combined cardiovascular end-point of death, non-fatal myocardial infarction, stroke and\n      revascularizations with at least 30%."
        }, 
        "brief_title": "Omega-3 Fatty Acids in Elderly Patients With Acute Myocardial Infarction", 
        "completion_date": {
            "#text": "November 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Myocardial Infarction", 
            "Heart Failure", 
            "Myocardial Revascularization", 
            "Atrial Fibrillation"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Atrial Fibrillation", 
                "Heart Failure", 
                "Infarction", 
                "Myocardial Infarction"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with acute myocardial infarction discharged from hospital alive\n\n        Exclusion Criteria:\n\n          -  Being part of another randomized trial\n\n          -  Documented intolerance for omega-3 fatty acids\n\n          -  Additional disease state that is thought to be incompatible with compliance to the\n             study drugs\n\n          -  Additional disease state thought to reduce survival for the follow-up time of 2 years"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "82 Years", 
            "minimum_age": "70 Years"
        }, 
        "enrollment": {
            "#text": "1400", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01841944", 
            "org_study_id": "2012/14890", 
            "secondary_id": "2012-004478-25"
        }, 
        "intervention": [
            {
                "arm_group_label": "Pikasol", 
                "description": "Pikasol\u00ae, 3 capsules (1.8 g EPA+DHA)/day", 
                "intervention_name": "Pikasol", 
                "intervention_type": "Drug", 
                "other_name": [
                    "omega-3", 
                    "polyunsaturated fatty acids"
                ]
            }, 
            {
                "arm_group_label": "Corn oil", 
                "description": "Corn oil (56% linoleic acid, 32% oleic acid, 10% palmitic acid), unchanged and according to the manufacturer", 
                "intervention_name": "Corn oil", 
                "intervention_type": "Other", 
                "other_name": "Corn oil"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Fatty Acids, Omega-3", 
            "Aged", 
            "Myocardial Infarction"
        ], 
        "lastchanged_date": "April 24, 2013", 
        "location": [
            {
                "contact": {
                    "email": "arnljot.tveit@vestreviken.no", 
                    "last_name": "Arnljot Tveit, MD Phd"
                }, 
                "facility": {
                    "address": {
                        "city": "Rud", 
                        "country": "Norway", 
                        "state": "B\u00e6rum", 
                        "zip": "1309"
                    }, 
                    "name": "Asker and B\u00e6rum Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "P\u00e5l Smith, MD Phd"
                }, 
                "facility": {
                    "address": {
                        "city": "L\u00f8renskog", 
                        "country": "Norway", 
                        "zip": "1478"
                    }, 
                    "name": "Akershus university hospital HF"
                }, 
                "investigator": {
                    "last_name": "Peder Myhre, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oslo", 
                        "country": "Norway", 
                        "zip": "0424"
                    }, 
                    "name": "Oslo University Hospital(Ullevaal)"
                }, 
                "investigator": {
                    "last_name": "Kristian Laake, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Norway"
        }, 
        "number_of_arms": "2", 
        "official_title": "Giving Omega-3 Fatty Acids to Elderly Patients Diagnosed With Acute Myocardial Infarction to Investigate the Effect on Cardiovascular Morbidity and Mortality", 
        "overall_contact": {
            "email": "svein.solheim@ous-hf.no", 
            "last_name": "Svein Solheim, MD Phd", 
            "phone": "23027541", 
            "phone_ext": "+47"
        }, 
        "overall_official": [
            {
                "affiliation": "Center for Clinical Heart Research", 
                "last_name": "Harald Arnesen, MD Phd", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Center for Clinical Heart Research", 
                "last_name": "Svein Solheim, MD phd", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Center for Clinical Heart Research", 
                "last_name": "Ingebj\u00f8rg Seljeflot, Phd", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Center for Clinical Heart Research", 
                "last_name": "Kristian Laake, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Center for Clinical Heart Research", 
                "last_name": "Peder Myhre, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Norway:National Committee for Medical and Health Research Ethics", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Combined total mortality, first event of non-fatal myocardial infarction, stroke and revascularization.", 
            "safety_issue": "No", 
            "time_frame": "24months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01841944"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Occurence of new onset atrial fibrillation", 
            "safety_issue": "No", 
            "time_frame": "24months"
        }, 
        "source": "Oslo University Hospital", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "University Hospital, Akershus", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Asker & Baerum Hospital", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Oslo University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}